Business Description
Amoeba SA
ISIN : FR0011051598
Compare
Compare
Traded in other countries / regions
ALMIB.FranceA1H.Germany0RAE.UK IPO Date
2015-07-10Description
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.7 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 23.7 | |||||
| 3-Year EPS without NRI Growth Rate | 36.9 | |||||
| 3-Year FCF Growth Rate | 28.3 | |||||
| 3-Year Book Growth Rate | -19.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.71 | |||||
| 9-Day RSI | 70.35 | |||||
| 14-Day RSI | 61.32 | |||||
| 6-1 Month Momentum % | 4.03 | |||||
| 12-1 Month Momentum % | -32.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 1.23 | |||||
| Cash Ratio | 0.83 | |||||
| Days Inventory | 58.64 | |||||
| Days Payable | 100.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -54.9 | |||||
| Shareholder Yield % | 34.62 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -118.52 | |||||
| ROA % | -66.26 | |||||
| ROIC % | -70.28 | |||||
| ROC (Joel Greenblatt) % | -232.41 | |||||
| ROCE % | -112.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.25 | |||||
| Price-to-Tangible-Book | 5.44 | |||||
| EV-to-EBIT | -2.62 | |||||
| EV-to-EBITDA | -3.06 | |||||
| EV-to-Forward-EBITDA | -2.69 | |||||
| EV-to-FCF | -3.26 | |||||
| Price-to-Net-Current-Asset-Value | 43.5 | |||||
| Earnings Yield (Greenblatt) % | -38.17 | |||||
| FCF Yield % | -26.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amoeba SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.12 | ||
| Beta | 0.06 | ||
| Volatility % | 43.32 | ||
| 14-Day RSI | 61.32 | ||
| 14-Day ATR (€) | 0.022414 | ||
| 20-Day SMA (€) | 0.4036 | ||
| 12-1 Month Momentum % | -32.3 | ||
| 52-Week Range (€) | 0.365 - 0.704 | ||
| Shares Outstanding (Mil) | 49.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amoeba SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amoeba SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Amoeba SA Frequently Asked Questions
What is Amoeba SA(XPAR:ALMIB)'s stock price today?
The current price of XPAR:ALMIB is €0.43. The 52 week high of XPAR:ALMIB is €0.70 and 52 week low is €0.37.
When is next earnings date of Amoeba SA(XPAR:ALMIB)?
The next earnings date of Amoeba SA(XPAR:ALMIB) is .
Does Amoeba SA(XPAR:ALMIB) pay dividends? If so, how much?
Amoeba SA(XPAR:ALMIB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers